Commitment COM-121
Post-approval commitment for FDA-2024-0021. Category: Paediatric Study. Priority: medium.
Commitment ID
COM-121
Application
Authority
Food and Drug Administration
Category
Paediatric Study
Priority
medium
Status
Open
Due Date
2025-05-05
Completed At
—
Owner
James O'Brien
Created
2022-10-31
Description
Provide 36-month accelerated stability data for 25°C/60% RH condition
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.